Conflict of Laws

Read Science, Computers & Technology updates, news, alerts, and legal analysis from leading lawyers and law firms:

News & Analysis as of May 24, 2013

Compounding Animal Drugs from Bulk Ingredients

by Duane Morris LLP on 4/17/2013

Recent public discussion about the federal role in regulating compounding pharmacies has focused on compounded drugs for human use. Compounded drugs are also vital to companion animal health (like pets). In the world of...more

Circuit Split: How Does the CFAA Apply to Employment Cases?

by Cullen and Dykman LLP on 10/15/2012

Imagine a disgruntled employee rummaging through your company’s confidential files and covertly stealing trade secrets to use as he builds a competing business. What recourse would you have against the rogue employee?...more

4th Circuit Issues Employee Friendly CFAA Opinion

by Fisher & Phillips LLP on 8/3/2012

As readers of this blog know, we have been following the diverse and seemingly irreconciliable decisions from federal courts regarding the scope of the federal Computer Fraud and Abuse Act ("CFAA"), 18 U.S.C. § 1030. Last...more

Fourth Circuit Decision Deepens Split of Authority on Federal Computer Fraud and Abuse Act's Prohibition on Conduct that "Exceeds...

by Davis Wright Tremaine LLP on 8/2/2012

The U.S. Court of Appeals for the 4th Circuit has issued a ruling in WEC Carolina Energy Solutions v. Miller, holding that the federal Computer Fraud and Abuse Act (“CFAA”) prohibition on exceeding “authorized access” to a...more

Federal Trade Commission v. Watson Pharmaceuticals, Inc. (11th Cir. 2012)

by McDonnell Boehnen Hulbert & Berghoff LLP on 5/1/2012

The practice of "reverse payments" in ANDA litigation (where, typically, the branded drug manufacturer settles litigation brought under 35 U.S.C. § 271(e)(2) with a generic challenger) have been a thorn in the side of the...more

Classen v. Biogen Idec et al. – The Latest Installment in the Patent-Eligibility Arena

by Fenwick & West LLP on 10/10/2011

On August 31, 2011, the Federal Circuit issued its long-awaited decision in Classen Immunotherapies, Inc. v. Biogen Idec et al. The case was remanded by the Supreme Court back to the Federal Circuit with instructions to...more

Health Law Alert 2010 Volume 2: Physician Payment Sunshine Act

by Ober|Kaler on 12/20/2010

The Patient Protection and Affordable Health Care Act (H.R. 3590) signed into law in March 2010 includes the Physician Payment Sunshine Act (section 6002) (PPSA), which requires pharmaceutical, medical device, biological, and...more

Electronic records mandates may clash with privacy laws: Patchwork of state laws adds complexity By Eric A. Klein and Christine C....

by Sheppard Mullin Richter & Hampton LLP on 6/8/2009

President Obama has declared that electronic medical records will “reduce error rates, reduce our long-term cost of health care and create jobs.” “Obama’s Prime Time Press Briefing,” N.Y. Times, Feb. 9, 2009. Congress has...more

Wyeth v. Levine: No Federal Preemption for Drug Labeling

by Foley Hoag LLP on 3/5/2009

The Supreme Court yesterday decided Wyeth v. Levine, the long-awaited decision on preemption of state court product liability claims against the pharmaceutical manufacturers. In a 6 to 3 decision, the Supreme Court determined...more